Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 1
This study looked at the dose of selumetinib that you can safely have with radiotherapy to treat non small cell lung cancer (NSCLC).
It was for people who had non small cell lung cancer (NSCLC) that was either:
Recruitment start: 1 June 2010
Recruitment end: 10 February 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Corinne Faivre-Finn
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
The Christie NHS Foundation Trust
University of Manchester
Last reviewed: 03 Jan 2018
CRUK internal database number: 7596
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
